Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2025-12-25 @ 11:26 PM
Study NCT ID:
NCT03439293
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2018-02-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-14
First Submit QC Date:
None
Study First Post Date:
2018-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-20
Results First Submit QC Date:
None
Results First Post Date:
2023-02-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-07
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL